Raltegravir-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: implications for clinical practice and patient safety

Introduction: Integrase inhibitor raltegravir is being used increasingly in patients with potential drug interactions [1]. We describe a case of DRESS syndrome in a patient who was switched to raltegravir from a PI based regime. Supplement: Abstracts of the Tenth International Congress on Drug Therapy in HIV Infection http://www.biomedcentral.com/content/pdf/1758-2652-13-S4-info.pdf Conference: Tenth International Congress on Drug Therapy in HIV Infection 7-11 November 2010 Glasgow, UK (Published. 8 November 2010) doi:10.1186/1758-2652-13-S4-P110 Cite this article as: Perry et al.: Raltegravir-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: implications for clinical practice and patient safety. Journal of the International AIDS Society 2010 13(Suppl 4):P110. Full text: PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3112885/